|Position||Trades||Duration||Win rate||Win/loss||Avg win||Avg loss||Return|
|Position||Trades||Duration||Win Rate||Win/Loss||Avg Win||Avg Loss||Return|
Trading: SELL @ $208.77
Signal Strength: STRONG
Indicator is best used in conjunction with additional indicators as it has the ability to highlight potential overbought or oversold levels. This indicator utilizes upper and lower bands to visually represent price extremes associated with the bands. Additional value can be added to the trading strategy by accessing divergences between price and volume.
Cochlear (ASX:COH) is currently bearish highlighting the potential for a short term trend continuation in the downward direction.
The Donchian channel is a useful indicator for seeing the volatility of a market price. If a price is stable the Donchian channel will be relatively narrow. If the price fluctuates a lot the Donchian channel will be wider. The two outer bands are plotted as the highest high and lowest low for a set period originally 20 days with the optional middle band calculated as the average of the two.
Calculation: Donchian Channels:
1) Upper Channel = 20 Day High;
2) Lower Channel = 20 Day Low;
3) Middle Channel = (20 Day High + 20 Day Low)/2;
PROFILE: Cochlear (COH.AX)
Stock Exchange: ASX
Ticker Codes: | COH.AX | ASX:COH |
Cochlear Limited provides implantable hearing solutions. The company offers cochlear implants, including Nucleus 6 system and Kanso sound processors; Carina middle-ear implants and accessories; Baha bone conduction implants, such as Baha attract system, Baha connect system, Baha softband, Baha 5 sound processor, Baha 5 power, Baha 5 superpower, other sound processors, and wireless accessories; and Cochlear true Wireless devices comprising mini microphones, phone clips, and TV streamers. It also provides Cochlear Vistafix bone-anchored facial prosthetic solutions to enhance the attachment and cosmetic outcome of facial prostheses. The company sells its products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cochlear Limited has a strategic collaboration with Sensorion to focus on improving hearing outcomes in patients with cochlear implants. The company was incorporated in 1983 and is headquartered in Sydney, Australia.
|ALK Alkane Exploration||0.71||11.9||5,930,185||34.91||BULLISH|
|CVW Clearview Wealth||0.7||7.7||158,305||12.5||BULLISH|
|PRU Perseus Mining||0.77||5.5||5,309,460||42.31||BULLISH|
|DCN Dacian Gold||1.36||4.6||5,417,629||24.7||BULLISH|